Tharmaseelan, H., Gillessen, S., Bühnen, I., Kobe, C., Schrenk, K. G., Topp, P. D. M. S., Schnetzke, U., Freund, N., Sasse, S., Ernst, P., Zamrik, T., Klapper, W., Fuchs, M., Borchmann, S., Bröckelmann, P., Borchmann, P., Tresckow, B. V. (2025). Pembro-CORE: Interim analysis of a phase II PET-adapted trial omitting high-dose chemotherapy with PD-1-based salvage in first-relapsed Hodgkin lymphoma. Blood. https://doi.org/10.1182/blood-2025-5401